These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 9056061
1. The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers. al-Shareef A, Buss DC, Shetty HG, Ali N, Routledge PA. Br J Clin Pharmacol; 1997 Jan; 43(1):109-11. PubMed ID: 9056061 [Abstract] [Full Text] [Related]
2. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion. Laine K, Kivistö KT, Ojala-Karlsson P, Neuvonen PJ. Ther Drug Monit; 1997 Feb; 19(1):46-50. PubMed ID: 9029746 [Abstract] [Full Text] [Related]
3. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L. Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [Abstract] [Full Text] [Related]
7. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate. Wangemann M, Retzow A, Vens-Cappell B. Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174 [Abstract] [Full Text] [Related]
8. Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram. Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ. Br J Clin Pharmacol; 1999 Aug; 48(2):148-53. PubMed ID: 10417490 [Abstract] [Full Text] [Related]
10. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. Keränen T, Sorri A, Moilanen E, Ylitalo P. Arzneimittelforschung; 2010 Aug; 60(7):421-6. PubMed ID: 20712131 [Abstract] [Full Text] [Related]
14. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination. Ho JL, Tierney MG, Dickinson GE. J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125 [Abstract] [Full Text] [Related]
17. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males. Stass H, Kubitza D, Möller JG, Delesen H. Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551 [Abstract] [Full Text] [Related]
18. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy. Ragueneau-Majlessi I, Levy RH, Brodie M, Smith D, Shah J, Grundy JS. Clin Pharmacokinet; 2005 May; 44(5):517-23. PubMed ID: 15871637 [Abstract] [Full Text] [Related]